AMETEK, Inc. $AME Shares Sold by Carnegie Investment Counsel

Carnegie Investment Counsel lowered its stake in shares of AMETEK, Inc. (NYSE:AMEFree Report) by 9.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 22,929 shares of the technology company’s stock after selling 2,437 shares during the period. Carnegie Investment Counsel’s holdings in AMETEK were worth $4,915,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Sivia Capital Partners LLC acquired a new stake in shares of AMETEK in the 2nd quarter worth approximately $295,000. Baird Financial Group Inc. raised its holdings in AMETEK by 16.1% during the second quarter. Baird Financial Group Inc. now owns 16,784 shares of the technology company’s stock worth $3,037,000 after purchasing an additional 2,323 shares during the last quarter. NewEdge Advisors LLC boosted its position in AMETEK by 65.0% during the second quarter. NewEdge Advisors LLC now owns 3,946 shares of the technology company’s stock worth $714,000 after purchasing an additional 1,555 shares in the last quarter. Sei Investments Co. grew its holdings in AMETEK by 38.2% in the second quarter. Sei Investments Co. now owns 223,227 shares of the technology company’s stock valued at $40,392,000 after purchasing an additional 61,672 shares during the last quarter. Finally, Squarepoint Ops LLC increased its position in shares of AMETEK by 105.3% in the second quarter. Squarepoint Ops LLC now owns 158,274 shares of the technology company’s stock valued at $28,641,000 after buying an additional 81,178 shares in the last quarter. 87.43% of the stock is currently owned by institutional investors and hedge funds.

AMETEK Stock Down 0.1%

Shares of NYSE AME opened at $233.85 on Monday. AMETEK, Inc. has a 1 year low of $174.43 and a 1 year high of $244.71. The firm’s 50 day moving average price is $231.21 and its 200 day moving average price is $225.60. The firm has a market cap of $53.60 billion, a P/E ratio of 35.32, a price-to-earnings-growth ratio of 3.28 and a beta of 0.99. The company has a debt-to-equity ratio of 0.10, a quick ratio of 0.72 and a current ratio of 1.14.

AMETEK (NYSE:AMEGet Free Report) last issued its quarterly earnings results on Thursday, April 30th. The technology company reported $1.97 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.07. AMETEK had a return on equity of 16.63% and a net margin of 20.11%.The company had revenue of $1.93 billion during the quarter, compared to the consensus estimate of $1.91 billion. During the same period in the previous year, the firm posted $1.75 EPS. AMETEK’s revenue was up 11.3% on a year-over-year basis. AMETEK has set its FY 2026 guidance at 7.940-8.140 EPS and its Q2 2026 guidance at 1.960-2.000 EPS. As a group, sell-side analysts anticipate that AMETEK, Inc. will post 8.14 earnings per share for the current year.

AMETEK Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th were given a $0.34 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.6%. AMETEK’s payout ratio is currently 20.54%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Robert W. Baird set a $244.00 price target on AMETEK in a research note on Friday, May 1st. Wall Street Zen cut shares of AMETEK from a “buy” rating to a “hold” rating in a research report on Sunday, May 10th. Truist Financial increased their price target on shares of AMETEK from $275.00 to $303.00 and gave the company a “buy” rating in a research report on Thursday, July 2nd. Royal Bank Of Canada lifted their price objective on AMETEK from $259.00 to $260.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. Finally, DA Davidson reaffirmed a “buy” rating and issued a $265.00 target price on shares of AMETEK in a research note on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $256.29.

Read Our Latest Stock Analysis on AMETEK

AMETEK Profile

(Free Report)

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.

Featured Articles

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.